ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/12/14 | 1,921 | 1,948 | 1,915 | 1,931 | +11 | +0.6% | 50,500 |
2020/12/11 | 1,911 | 1,923 | 1,900 | 1,920 | +3 | +0.2% | 76,500 |
2020/12/10 | 1,918 | 1,918 | 1,905 | 1,917 | -1 | -0.1% | 27,600 |
2020/12/09 | 1,902 | 1,918 | 1,896 | 1,918 | +22 | +1.2% | 32,500 |
2020/12/08 | 1,878 | 1,905 | 1,862 | 1,896 | +11 | +0.6% | 62,200 |
2020/12/07 | 1,862 | 1,891 | 1,860 | 1,885 | +8 | +0.4% | 84,200 |
2020/12/04 | 1,854 | 1,879 | 1,851 | 1,877 | +23 | +1.2% | 57,400 |
2020/12/03 | 1,870 | 1,883 | 1,848 | 1,854 | -21 | -1.1% | 68,500 |
2020/12/02 | 1,878 | 1,891 | 1,865 | 1,875 | -3 | -0.2% | 101,400 |
2020/12/01 | 1,872 | 1,899 | 1,856 | 1,878 | +10 | +0.5% | 57,000 |
2020/11/30 | 1,960 | 1,960 | 1,868 | 1,868 | -64 | -3.3% | 98,500 |
2020/11/27 | 1,899 | 1,950 | 1,895 | 1,932 | +51 | +2.7% | 120,200 |
2020/11/26 | 1,866 | 1,900 | 1,859 | 1,881 | +6 | +0.3% | 46,200 |
2020/11/25 | 1,914 | 1,914 | 1,872 | 1,875 | -15 | -0.8% | 53,600 |
2020/11/24 | 1,917 | 1,924 | 1,875 | 1,890 | +22 | +1.2% | 71,800 |
2020/11/20 | 1,877 | 1,891 | 1,866 | 1,868 | -36 | -1.9% | 79,600 |
2020/11/19 | 1,890 | 1,917 | 1,890 | 1,904 | -4 | -0.2% | 41,300 |
2020/11/18 | 1,901 | 1,925 | 1,893 | 1,908 | -16 | -0.8% | 52,600 |
2020/11/17 | 1,928 | 1,937 | 1,901 | 1,924 | -14 | -0.7% | 59,900 |
2020/11/16 | 1,963 | 1,963 | 1,929 | 1,938 | +14 | +0.7% | 67,700 |
2020/11/13 | 1,967 | 1,967 | 1,921 | 1,924 | -43 | -2.2% | 29,900 |
2020/11/12 | 1,968 | 1,970 | 1,940 | 1,967 | ±0 | ±0% | 43,000 |
2020/11/11 | 1,974 | 1,977 | 1,942 | 1,967 | +30 | +1.5% | 63,200 |
2020/11/10 | 1,914 | 1,954 | 1,914 | 1,937 | +17 | +0.9% | 78,700 |
2020/11/09 | 1,910 | 1,929 | 1,892 | 1,920 | +10 | +0.5% | 55,300 |
2020/11/06 | 1,957 | 1,957 | 1,909 | 1,910 | -51 | -2.6% | 71,200 |
2020/11/05 | 1,867 | 1,963 | 1,845 | 1,961 | +73 | +3.9% | 173,500 |
2020/11/04 | 1,915 | 1,915 | 1,877 | 1,888 | +19 | +1% | 74,000 |
2020/11/02 | 1,864 | 1,899 | 1,856 | 1,869 | +17 | +0.9% | 55,300 |
2020/10/30 | 1,854 | 1,873 | 1,837 | 1,852 | -2 | -0.1% | 50,000 |
2020/10/29 | 1,827 | 1,865 | 1,827 | 1,854 | +9 | +0.5% | 25,900 |
2020/10/28 | 1,832 | 1,846 | 1,822 | 1,845 | -2 | -0.1% | 40,900 |
2020/10/27 | 1,836 | 1,870 | 1,826 | 1,847 | +4 | +0.2% | 27,200 |
2020/10/26 | 1,839 | 1,855 | 1,833 | 1,843 | +3 | +0.2% | 26,600 |
2020/10/23 | 1,845 | 1,866 | 1,839 | 1,840 | -1 | -0.1% | 29,200 |
2020/10/22 | 1,876 | 1,876 | 1,841 | 1,841 | -35 | -1.9% | 41,800 |
2020/10/21 | 1,850 | 1,895 | 1,850 | 1,876 | +29 | +1.6% | 29,900 |
2020/10/20 | 1,887 | 1,887 | 1,847 | 1,847 | -39 | -2.1% | 47,000 |
2020/10/19 | 1,878 | 1,910 | 1,878 | 1,886 | +12 | +0.6% | 35,200 |
2020/10/16 | 1,890 | 1,899 | 1,871 | 1,874 | -26 | -1.4% | 29,400 |
2020/10/15 | 1,922 | 1,934 | 1,896 | 1,900 | -41 | -2.1% | 38,100 |
2020/10/14 | 1,957 | 1,977 | 1,937 | 1,941 | -27 | -1.4% | 24,900 |
2020/10/13 | 1,987 | 1,987 | 1,957 | 1,968 | -21 | -1.1% | 31,800 |
2020/10/12 | 1,988 | 1,994 | 1,961 | 1,989 | +14 | +0.7% | 31,900 |
2020/10/09 | 2,004 | 2,005 | 1,968 | 1,975 | -29 | -1.4% | 31,500 |
2020/10/08 | 2,009 | 2,017 | 1,996 | 2,004 | +13 | +0.7% | 41,900 |
2020/10/07 | 1,999 | 2,004 | 1,977 | 1,991 | -18 | -0.9% | 35,700 |
2020/10/06 | 1,991 | 2,013 | 1,973 | 2,009 | +17 | +0.9% | 25,400 |
2020/10/05 | 1,984 | 2,018 | 1,982 | 1,992 | +29 | +1.5% | 38,500 |
2020/10/02 | 2,010 | 2,033 | 1,950 | 1,963 | - | - | 45,100 |
1151~
1200
件表示中 / 3770件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 204,700円 | +3.1% | -6.5% | 2.34% | 9.50倍 | 1.01倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ジーエヌアイ | 265,700円 | +21.7% | +999.9% | 0.00% | 12.24倍 | 4.19倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 311,500円 | +5.1% | -7.0% | 2.57% | 20.45倍 | 0.84倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
栄研化 | 241,900円 | +4.1% | -3.1% | 2.40% | 21.01倍 | 1.83倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
杏林製薬 | 152,500円 | -2.4% | -52.3% | 3.74% | 18.25倍 | 0.64倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム